Rob C.M. Pelger

Dr. Rob C.M. Pelger

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 June 2010 in Cancer Research
Verified
Journal Article
Closed access
PDF file
CHChristel van Den Hoogen
Christel van Den Hoogen
GHGeertje van der Horst
Geertje van der Horst
HCHenry Cheung
Henry Cheung
Jeroen BuijsJeroen Buijs
Jeroen Buijs
JLJenny M. Lippitt
Jenny M. Lippitt
GPGabri van der Pluijm
Gabri van der Pluijm
Metastatic progression of advanced prostate cancer is a major clinical problem. Identifying the cell(s) of origin in prostate cancer and its distant metastases may permit the development of more effective treatment and preventive therapies. In this study, aldehyde dehydrogenase (ALDH) activity was used as a basis to isolate and compare subpopulations of primary human prostate cancer cells and cell lines. ALDH-high prostate cancer cells displayed strongly elevated clonogenicity and migratory behavior in vitro. More strikingly, ALDH-high cells readily formed distant metastases with strongly enhanced tumor progression at both orthotopic and metastatic sites in preclinical models. Several ALDH isoforms were expressed in human prostate cancer cells and clinical specimens of primary prostate tumors with matched bone metastases. Our findings suggest that ALDH-based viable cell sorting can be used to identify and characterize tumor-initiating and, more importantly perhaps, metastasis-initiating cells in human prostate cancer. Cancer Res; 70(12); 5163–73. ©2010 AACR.

1 September 2007 in The American Journal of Pathology
Verified
Journal Article
Closed access
Jeroen BuijsJeroen Buijs
Jeroen Buijs
CRCyrill A. Rentsch
Cyrill A. Rentsch
GHGeertje van der Horst
Geertje van der Horst
POPetra G.M. van Overveld
Petra G.M. van Overveld
AWAntoinette Wetterwald
Antoinette Wetterwald
GPGabri van der Pluijm
Gabri van der Pluijm

7 June 2011 in Clinical & Experimental Metastasis
Verified
Journal Article
Open access
PDF file
CHChristel van Den Hoogen
Christel van Den Hoogen
GHGeertje van der Horst
Geertje van der Horst
HCHenry Cheung
Henry Cheung
Jeroen BuijsJeroen Buijs
Jeroen Buijs
RPRob C.M. Pelger
Rob C.M. Pelger
GPGabri van der Pluijm
Gabri van der Pluijm
High aldehyde dehydrogenase (ALDH) activity can be used to identify tumor-initiating and metastasis-initiating cells in various human carcinomas, including prostate cancer. To date, the functional importance of ALDH enzymes in prostate carcinogenesis, progression and metastasis has remained elusive. Previously we identified strong expression of ALDH7A1 in human prostate cancer cell lines, primary tumors and matched bone metastases. In this study, we evaluated whether ALDH7A1 is required for the acquisition of a metastatic stem/progenitor cell phenotype in human prostate cancer. Knockdown of ALDH7A1 expression resulted in a decrease of the α2hi/αvhi/CD44+ stem/progenitor cell subpopulation in the human prostate cancer cell line PC-3M-Pro4. In addition, ALDH7A1 knockdown significantly inhibited the clonogenic and migratory ability of human prostate cancer cells in vitro. Furthermore, a number of genes/factors involved in migration, invasion and metastasis were affected including transcription factors (snail, snail2, and twist) and osteopontin, an ECM molecule involved in metastasis. Knockdown of ALDH7A1 resulted in decreased intra-bone growth and inhibited experimentally induced (bone) metastasis, while intra-prostatic growth was not affected. In line with these observations, evidence is presented that TGF-β, a key player in cancer invasiveness and bone metastasis, strongly induced ALDH activity while BMP7 (an antagonist of TGF-β signaling) down-regulated ALDH activity. Our findings show, for the first time, that the ALDH7A1 enzyme is functionally involved in the formation of bone metastases and that the effect appeared dependent on the microenvironment, i.e., bone versus prostate.

1 February 2008 in The Journal of Sexual Medicine
Verified
Journal Article
Closed access
PDF file
HEHenk Willem Elzevier
Henk Willem Elzevier
HPHein Putter
Hein Putter
KDKarl P.J. Delaere
Karl P.J. Delaere
PVPieter L. Venema
Pieter L. Venema
ANA.A.B. Lycklama À Nijeholt
A.A.B. Lycklama À Nijeholt
RPRob C.M. Pelger
Rob C.M. Pelger

1 November 2011 in The American Journal of Pathology
Verified
Journal Article
Closed access
CHChristel van Den Hoogen
Christel van Den Hoogen
GHGeertje van der Horst
Geertje van der Horst
HCHenry Cheung
Henry Cheung
Jeroen BuijsJeroen Buijs
Jeroen Buijs
RPRob C.M. Pelger
Rob C.M. Pelger
GPGabri van der Pluijm
Gabri van der Pluijm

12 September 2012 in Neurourology and Urodynamics
Verified
Journal Article
Closed access
PDF file
PZPetra J. Voorham‐Van der Zalm
Petra J. Voorham‐Van der Zalm
JVJeroen C. Voorham
Jeroen C. Voorham
TBTine W.L. van Den Bos
Tine W.L. van Den Bos
TOTheo J. Ouwerkerk
Theo J. Ouwerkerk
HPHein Putter
Hein Putter
RPRob C.M. Pelger
Rob C.M. Pelger